Thrombotic Thrombocytopenic Purpura Cases and Consumption of Large Quantities of Energy Drink: Related or Coincidence?
Case report
Energy drink
Thrombotic thrombocytopenic purpura
Toxicity
Journal
Acta haematologica
ISSN: 1421-9662
Titre abrégé: Acta Haematol
Pays: Switzerland
ID NLM: 0141053
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
03
2019
accepted:
29
04
2019
pubmed:
6
6
2019
medline:
24
4
2020
entrez:
6
6
2019
Statut:
ppublish
Résumé
The vast majority of cases of thrombotic thrombocytopenic purpura (TTP) are the result of acquired antibodies which inhibit the activity of the ADAMTS13 enzyme. Acquired TTP is more frequently seen in young females or in individuals with autoimmune disease. The development of antibodies against ADAMTS13 may also result from the administration or consumption of drugs and other substances. However, specific laboratory tests to identify the pathogenic mechanism of a particular drug may not be available, and the role of a potentially implicated drug or other ingested substance may not be clear. In this report we present 2 acquired TTP cases involving the consumption of a large amount of energy drink.
Identifiants
pubmed: 31167181
pii: 000500665
doi: 10.1159/000500665
doi:
Substances chimiques
Rituximab
4F4X42SYQ6
ADAMTS13 Protein
EC 3.4.24.87
ADAMTS13 protein, human
EC 3.4.24.87
Methylprednisolone
X4W7ZR7023
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
176-180Informations de copyright
© 2019 S. Karger AG, Basel.